The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens

被引：1289
|
作者：
Wyatt, R
Sodroski, J [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol AIDS,Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
来源：
SCIENCE | 1998年 / 280卷 / 5371期
关键词：
D O I：
10.1126/science.280.5371.1884
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The human immunodeficiency virus-type 1 (HIV-1) envelope glycoproteins interact with receptors on the target cell and mediate virus entry by fusing the viral and cell membranes. The structure of the envelope glycoproteins has evolved to fulfill these functions while evading the neutralizing antibody response. An understanding of the viral strategies for immune evasion should guide attempts to improve the immunogenicity of the HIV-1envelope glycoproteins and, ultimately, aid in HIV-1vaccine development.
引用
收藏
页码：1884 / 1888
页数：5
相关论文
共 50 条
  • [31] Triazine dyes inhibit HIV-1 entry by binding to envelope glycoproteins
    Hattori, T
    Zhang, XY
    Weiss, C
    Xu, YN
    Kubo, T
    Sato, Y
    Nishikawa, S
    Sakaida, H
    Uchiyama, T
    MICROBIOLOGY AND IMMUNOLOGY, 1997, 41 (09) : 717 - 724
  • [32] Antibacterial activity of peptides derived from envelope glycoproteins of HIV-1
    Cole, AM
    Liao, H
    Ganz, T
    Yang, OO
    FEBS LETTERS, 2003, 535 (1-3) : 195 - 199
  • [33] Recent Advances on the Use of Structural Biology for the Design of Novel Envelope Immunogens of HIV-1
    Xiang, Shi-Hua
    CURRENT HIV RESEARCH, 2013, 11 (06) : 464 - 472
  • [34] HIV-1 Diversity in the Envelope Glycoproteins: Implications for Viral Entry Inhibition
    Luvison Araujo, Leonardo Augusto
    Almeida, Sabrina E. M.
    VIRUSES-BASEL, 2013, 5 (02): : 595 - 604
  • [35] Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins
    Schiffner, Torben
    Pallesen, Jesper
    Russell, Rebecca A.
    Dodd, Jonathan
    de Val, Natalia
    LaBranche, Celia C.
    Montefiori, David
    Tomaras, Georgia D.
    Shen, Xiaoying
    Harris, Scarlett L.
    Moghaddam, Amin E.
    Kalyuzhniy, Oleksandr
    Sanders, Rogier W.
    McCoy, Laura E.
    Moore, John P.
    Ward, Andrew B.
    Sattentau, Quentin J.
    PLOS PATHOGENS, 2018, 14 (05)
  • [36] VIRUS INHIBITORY ACTIVITY OF PEPTIDES FROM THE ENVELOPE GLYCOPROTEINS OF HIV-1
    JIANG, S
    LIN, K
    STRICK, N
    NEURATH, AR
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 81 - 81
  • [37] Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins
    Kothe, Denise L.
    Decker, Julie M.
    Li, Yingying
    Weng, Zhiping
    Bibollet-Ruche, Frederic
    Zammit, Kenneth P.
    Salazar, Maria G.
    Chen, Yalu
    Salazar-Gonzalez, Jesus F.
    Moldoveanu, Zina
    Mestecky, Jiri
    Gao, Jeng
    Haynes, Barton F.
    Shaw, George M.
    Muldoon, Mark
    Korber, Bette T. M.
    Hahn, Beatrice H.
    VIROLOGY, 2007, 360 (01) : 218 - 234
  • [38] EXPRESSION OF HIV-1 ENVELOPE GLYCOPROTEINS BY SEMLIKI FOREST VIRUS VECTORS
    PAUL, NL
    MARSH, M
    MCKEATING, JA
    SCHULZ, TF
    LILJESTROM, P
    GAROFF, H
    WEISS, RA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (10) : 963 - 970
  • [39] Role of Adjuvants in Enhancing the Immunogenicity of HIV-1 Envelope Glycoprotein based Vaccine Immunogens
    Reddy, S.
    Chua, B.
    Kramski, M.
    Center, R.
    Jackson, D.
    Purcell, D.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A37 - A37
  • [40] Envelope-based HIV vaccine peptides as antigens in HIV-1 immunodiagnostics
    Department of Biochemistry, University of Johannesburg, Auckland Park Campus, P.O. Box 524, Johannesburg 2006, South Africa
    Int. J. Biotechnol., 2007, 3-4 (277-291):
12345